Source: Annual Congress 2002 - Lung infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ohno, N. Saku, Y. Sugiyama (Kawachi/Minamikawachi, Japan). ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection. Eur Respir J 2002; 20: Suppl. 38, 2817

Member's Comments

No comment yet.

Related content which might interest you: Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007 Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Anti-neutrophil cytoplasmic antibodies and immune complexes vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=91 Year: 2005 Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009 The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis Source: Eur Respir J 2011; 37: 1503-1513 Year: 2011 Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection? Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006 The role of IgA in recurrent respiratory infections (RRIs) in children Source: Eur Respir J 2001; 18: Suppl. 33, 106s Year: 2001 Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy Source: Eur Respir J 2015; 46: 554-557 Year: 2015 IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Lower concentration of anti-capsular polysaccharide IgG antibodies (AB) in patients with pneumococcal respiratory tract infections (RTI) Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies. Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020